Inflammatory bowel disease (IBD) is a chronic inflammatory condition with numerous nutrition implications, including an increased risk of malnutrition and various nutrient deficiencies. Surgical interventions are often necessary in the treatment of IBD, and patients with IBD presenting for surgery often have multiple issues, including acute inflammatory processes, malnutrition, anemia, and infections, which may increase the likelihood of poor surgical outcomes. Thus, determining adjunctive treatments that may decrease postoperative complications is paramount. Although enteral nutrition (EN) is considered the preferred nutrition support modality when the gastrointestinal tract is accessible and functional, parenteral nutrition (PN) may provide a suitable alternative when the use of EN is not feasible. The aim of this review is to evaluate the currently available literature on the impact of perioperative PN on postoperative complications, disease severity, and nutrition status in adults with IBD. Six studies within the past 10 years investigated this topic and are analyzed here. Results indicate general trends toward improvements in postoperative outcomes, disease severity, and nutrition status associated with perioperative PN use. Although results appear promising, additional, larger studies with an emphasis on PN composition will improve our understanding of the benefits of perioperative PN in adults with IBD.
KappelmanMDRifas-ShimanSLKleinmanK. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
2.
LoftusEV.Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
EwaldPWEwaldHA.An evolutionary perspective on the causes and treatment of inflammatory bowel disease. Curr Opin Gastroenterol, 2013;29:350-356.
5.
SartorRB.Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594.
6.
StroberWFussIMannonP.The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514-521.
7.
ShodaRMatsuedaKYamatoSUmedaN.Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;64:741-745.
8.
ForbesAGoldesgeymeEPaulonE.Nutrition in inflammatory bowel disease. J Parenter Enteral Nutr. 2011;35:571-580.
9.
KlementECohenRVBoxmanJJosephAReifS.Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342-1352.
10.
BaumgartDCSandbornWJ.Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1647.
11.
MowatCColeAWindsorA. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607.
12.
SatsangiJSilverbergMSVermeireSColombelJF.The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
13.
SilverbergMSSatsangiJAhmadT. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.
14.
KornbluthASacharDB.Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
15.
LaassMWRoggenbuckDConradK.Diagnosis and classification of Crohn’s disease. Autoimmunity Rev. 2014;13:467-471.
16.
BestWRBecktelJMSingletonJWKernF.Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology, 1976;70:439-444.
17.
VermeireSVan AsscheGRutgeertsP.Classification of inflammatory bowel disease: the old and the new. Curr Opin Gastroenterol. 2012;28:321-326.
18.
GascheCScholmerichJBrynskovJ. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
19.
CarterDEliakimR.Current role of endoscopy in inflammatory bowel disease diagnosis and management. Curr Opin Gastroenterol. 2014;30:370-377.
20.
LewisJD.The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011;140:1817-1826.
21.
AggioRProbertC.Future methods for the diagnosis of inflammatory bowel disease. Dig Dis. 2014;32:463-467.
FrolkisADDykemanJNegronM. Risk of surgery for inflammatory bowel disease has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996-1006.
24.
SicaGSBianconeL.Surgery for inflammatory bowel disease in the era of laparoscopy. World J Gastroenterol. 2013;19:2445-2448.
25.
CimaRR.Surgical outcomes in inflammatory bowel disease patients and the potential impact of biologic therapies. Semin Colon Rectal Surg. 2012;23:89-93.
26.
IndarAAYoung-FadokTMHeppelJ. Effect of perioperative immunosuppressive medication on early outcome in Crohn’s disease patients. World J Surg. 2009;33:1049-1052.
27.
KunitakeHHodinRShellitoPC. Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg. 2008;12:1730-1736.
28.
AppauKAFazioVWShenB. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients. J Gastrointestinal Surg. 2008;12:1738-1744.
29.
ButterworthADThomasAGAkobergAK.Probiotics for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2008;(3):CD006634.
30.
NaidooKGordonMFagbemiAOThomasAGAkobengAK.Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2011;(12):CD007443.
31.
GhouriYARichardsDMRahimiEFKrillJTJelinekKADuPontAW.Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol. 2014;7:473-487.
32.
HarriesADJonesLAHeatleyRVRhodesJ.Malnutrition in inflammatory bowel disease: an anthropometric study. Hum Nutr Clin Nutr. 1982;36:307-313.
33.
MijacDDJankovicGLJJorgaJKrsticMN.Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med. 2010;21:315-319.
34.
NguyenGMunsellMHarrisM.Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis. 2008;14:1105-1111.
35.
WhiteJVGuenterPJensenG. Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). J Acad Nutr Diet. 2012;112:730-738.
36.
VagianosKBectorSMcConnellJBernsteinCN.Nutrition assessment of patients with inflammatory bowel disease. J Parenter Enteral Nutr. 2007;31:311-319.
37.
VagianosKClaraICarrR. What are adults with inflammatory bowel disease (IBD) eating? A closer look at the dietary habits of a population-based Canadian IBD cohort. JPEN J Parenter Enteral Nutr. 2016;40:405-411.
38.
TriantafillidisJKPapaloisAE.The role of total parenteral nutrition in inflammatory bowel disease: current aspects. Scand J Gastroenterol. 2014;49:3-14.
39.
RombeauJLBarotLRWilliamsonCEMullenJL.Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. Am J Surg. 1982;143:139-143.
40.
LashnerBAEvansAAHanauerSB.Preoperative total parenteral nutrition for bowel resection in Crohn’s disease. Dig Dis Sci. 1989;34:741-746.
41.
YaoGXWangXRJiangZMZhangSYNiAP.Role of perioperative parenteral nutrition in severely malnourished patients with Crohn’s disease. World J Gastroenterol. 2005;11:5732-5734.
42.
BregenholtSBrimnesJReimannJClaessonMH.Accumulation of immunoglobulin-containing cells in the gut mucosa and presence of faecal immunoglobulin in severe combined immunodeficient (scid) mice with T-cell-induced inflammatory bowel disease. Clin Exp Immunol. 1998;114:19-25.
43.
Grivceva StardelovaKMisevskaPZdravkovskaMTrajkovDSerafimoskiV. Total parenteral nutrition in treatment of patients with inflammatory bowel disease. Prilozi. 2008;29:21-43.
44.
WagnerIJRombeauJL.Nutritional support of surgical patients with inflammatory bowel disease. Surg Clin North Am. 2011;91:787-803.
45.
JacobsonS.Early postoperative complications in patients with Crohn’s disease given and not given preoperative total parenteral nutrition. Scand J Gastroenterol. 2012;47:170-177.
46.
SalinasHDursunAKonstantinidisI. Does preoperative total parenteral nutrition in patients with ulcerative colitis produce better outcomes?Int J Colorectal Dis. 2012;27:1479-1483.
O’GradyNPAlexanderMDellingerEP. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;12:759-769.
50.
DarouicheROBergerDHKhardoriN. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters—a randomized controlled study. Ann Surg. 2005;242:193-200.
51.
KrzywdaEAAndrisDAEdmistonCEWallaceJR. Parenteral access devices. In: GottschlichMM, ed. The A.S.P.E.N. Nutrition Support Core Curriculum: A Case-Based Approach—The Adult Patient. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2007:300-322.
52.
BeghettoMGVictorinoJTeixeiraLde AzevedoMJ.Parenteral nutrition as a risk factor for central venous catheter-related infection. JPEN J Parenter Enteral Nutr. 2005;29:367-373.
53.
YilmazGKoksalIAydinKCaylanRSucuNAksoyF.Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. JPEN J Parenter Enteral Nutr. 2007;31:284-287.
54.
ForchielliMLGuraKAnessi-PessinaERichardsonDCaiWLoCW.Success rates and cost-effectiveness of antibiotic combinations for initial treatment of central-venous-line infections during total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000;24:199-125.
55.
McClaveSAMartindaleRGVanekVW; A.S.P.E.N. Board of Directors; American College of Critical Care Medicine; Society of Critical Care Medicine. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33:277-316.
56.
BattistellaFDWidergrenJTAndersonJT. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma. 1997;43:52-58.
57.
Pontes-ArrudaALiuFXTurpinRSMercaldiCJHiseMZalogaG.Bloodstream infections in patients receiving manufactured parenteral nutrition with versus without lipids: is the use of lipids really deleterious?JPEN J Parenter Enteral Nutr. 2012;36:421-430.
58.
Grau-CarmonaTBonet-SarisAGarcia-de-LorenzoA. Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU Lipids Study. Crit Care Med. 2015;43:31-39.
59.
TianHYaoXZengR. Safety and efficacy of a new parenteral lipid emulsion (SMOF) for surgical patients: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2013;71:815-821.
60.
TsekosERueterCStehlePBoedenG.Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr. 2004;23:325-330.
61.
PuertollanoMAPuertollanoEDe CienfuegosGADe PabloMA.Impact of olive oil-based lipid emulsions in clinical nutrition: modulation of host defense. Nutr Ther Metab. 2010;28:161-171.
62.
BuschmannKPoeschlJBraachNHudallaHKussNFrommholdD.The olive oil-based lipid Clinoleic blocks leukocyte recruitment and improves survival during systemic inflammation: a comparative in vivo study of different parenteral lipid emulsions. Mediators Inflamm. 2015;2015:1-11.
63.
SchoepferAMVavrickaSZahnd-Straumann, StraumannABeglingerC.Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers. J Crohns Colitis. 2012;6:412-418.
64.
TappendenKAQuatraraBParkhurstMLMaloneAMFanjiangGZieglerTR.Critical role of nutrition in improving quality of care: an interdisciplinary call to action to address adult hospital malnutrition. JPEN J Parenter Enteral Nutr. 2013;37:482-497.
65.
BouillaneOHayPLiabaudBDucheCCynoberLAusselC.Evidence that albumin is not a suitable marker of body composition-related nutritional status in elderly patients. Nutrition. 2011;27:165-169.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
